Manufactured RBC - Rivers of blood, or an oasis in the desert?

Biotechnology Advances

Volumn 29, Issue 6, 2011, Pages 661-666

  Timmins, N E ^a   Nielsen, L K ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bioreactors; Blood transfusion; Cell culture; Cell therapy; Erythropoiesis; Red blood cells

Indexed keywords

BLOOD TRANSFUSION; CELL THERAPY; ERYTHROPOIESIS; IN-VITRO; LARGE SCALE MANUFACTURE; MODERN MEDICINE; RED BLOOD CELL; TECHNOLOGICAL DEVELOPMENT;

BIOREACTORS; BLOOD; STEM CELLS;

CELL CULTURE;

BIOREACTOR; BLOOD; CELL ORGANELLE; DESERT; MEDICINE; OASIS; TECHNOLOGICAL DEVELOPMENT;

ANIMAL; BIOLOGICAL THERAPY; BIOREACTOR; BLOOD TRANSFUSION; CULTURE TECHNIQUE; CYTOLOGY; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; PHYSIOLOGY; REVIEW; STEM CELL;

ANIMALS; BIOREACTORS; BLOOD TRANSFUSION; CELL CULTURE TECHNIQUES; ERYTHROCYTES; ERYTHROPOIESIS; HUMANS; STEM CELLS; TISSUE THERAPY;

EID: 80053435778     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.05.002     Document Type: Review

References (60)

1. Abbot S. The three "R"s of blood transfusion in 2020; routine, reliable and robust. Clin Lab Med 2010, 30(2):405-417.
2. Abe T., Masuda S., Ban H., Hayashi S., Ueda Y., Inoue M. Ex vivo expansion of human HSCs with Sendai virus vector expressing HoxB4 assessed by sheep in utero transplantation. Exp Hematol 2010, 39(1):47-54.
3. Air E.L., Strowski M.Z., Benoit S.C., Conarello S.L., Salituro G.M., Guan X.-M., et al. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat Med 2002, 8(2):179-183.
4. Andrade P.Z., dos Santos F., Almeida-Porada G., da Silva C.L., Cabral JMSS. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells. Mol Biosyst 2010, 6(7):1207-1215.
5. Antonchuk J., Sauvageau G., Humphries R.K. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp Hematol 2001, 29(9):1125-1134.
6. Baek E.J., Kim H.-S., Kim S., Jin H., Choi T.-Y., Kim H.O. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion 2008, 48(10):2235-2245.
7. Barbosa F.T., Jucá M.J., Castro A.A., Duarte J.L., Barbosa L.T. Artificial oxygen carriers as a possible alternative to red cells in clinical practice. Sao Paulo Med J 2009, 127(2):97-100.
8. Boehm D., Murphy W.G., Al-Rubeai M. The effect of mild agitation on in vitro erythroid development. J Immunol Methods 2010, 360(1-2):20-29.
9. Boitano A.E., Wang J., Romeo R., Bouchez L.C., Parker A.E., Sutton S.E., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329(5997):1345-1348.
10. Calvo K.R., Sykes D.B., Pasillas M.P., Kamps M.P. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene 2002, 21(27):4247-4256.
11. Chen J.-Y., Scerbo M., Kramer G. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics (Sao Paulo) 2009, 64(8):803-813.
12. Cohn C.S., Cushing M.M. Oxygen therapeutics: perfluorocarbons and blood substitute safety. Crit Care Clin 2009, 25(2):399-414.
13. Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R.L., Bernstein I.D. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010, 16(2):232-236.
14. Dellatore S.M., Garcia A.S., Miller W.M. Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol 2008, 19(5):534-540.
15. Di Maggio N., Piccinini E., Jaworski M., Trumpp A., Wendt D.J., Martin I. Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials 2011, 32(2):321-329.
16. Dietmair S, Nielsen LK, Timmins NE. Engineering a mammalian super producer - host cell engineering of mammalian cells. J Chem Technol Biotechnol In Press.
17. Doheny J.G., Jervis E.J., Guarna M.M., Humphries R.K., Warren R.A., Kilburn D.G. Cellulose as an inert matrix for presenting cytokines to target cells: production and properties of a stem cell factor-cellulose-binding domain fusion protein. Biochem J 1999, 339:429-434.
18. Domashenko A.D., Danet-Desnoyers G., Aron A., Carroll M.P., Emerson S.G. TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells. Blood 2010, 116(15):2676-2683.
19. Doran M.R., Markway B.D., Clark A., Athanasas-Platsis S., Brooke G., Atkinson K., et al. Membrane bioreactors enhance microenvironmental conditioning and tissue development. Tissue Eng Part C Methods 2010, 16(3):407-415.
20. Douay L., Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?. Transfus Med Rev 2007, 21(2):91-100.
21. Fujimi A., Matsunaga T., Kobune M., Kawano Y., Nagaya T., Tanaka I., et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol 2008, 87(4):339-350.
22. Furitsu T., Tsujimura T., Tono T., Ikeda H., Kitayama H., Koshimizu U., et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993, 92(4):1736-1744.
23. Giarratana M.-C., Kobari L., Lapillonne H., Chalmers D., Kiger L., Cynober T., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005, 23(1):69-74.
24. Gramer M.J., Maas J., Lieberman M.M. Use of hollow fiber systems for rapid and direct scale up of antibody production from hybridoma cell lines cultured in CL-1000 flasks using BD Cell MAb medium. Cytotechnology 2003, 42(3):155-162.
25. Gunawan R.C., King J.A., Lee B.P., Messersmith P.B., Miller W.M. Surface presentation of bioactive ligands in a nonadhesive background using DOPA-tethered biotinylated poly(ethylene glycol). Langmuir 2007, 23(21):10635-10643.
26. Haylock D.N., Nilsson S.K. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2007, 2(4):324-335.
27. Heike T., Nakahata T. Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim Biophys Acta 2002, 1592(3):313-321.
28. Hevehan D.L., Papoutsakis E.T., Miller W.M. Physiologically significant effects of pH and oxygen tension on granulopoiesis. Exp Hematol 2000, 28(3):267-275.
29. Hines M., Nielsen L., Cooper-White J. The hematopoietic stem cell niche: what are we trying to replicate?. J Chem Technol Biotechnol 2008, 83(4):421-443.
30. Hiroyama T., Miharada K., Sudo K., Danjo I., Aoki N., Nakamura Y. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 2008, 3(2):e1544.
31. Horton S.J., Williams O. The mechanism of hematopoietic progenitor cell immortalization by MLL-ENL. Cell Cycle 2006, 5(4):360-362.
32. Huang C.H., Chen P.M., Lu T.C., Kung W.M., Chiou T.J., Yang M.H., et al. Purified recombinant TAT-HOXB4 expands CD34+ umbilical cord blood and peripheral blood progenitor cells ex vivo. Tissue Eng Part C Methods 2009, 16(3):487-496.
33. Jain E., Kumar A. Upstream processes in antibody production: evaluation of critical parameters. Biotechnol Adv 2008, 26(1):46-72.
34. Jervis E.J., Guarna M.M., Doheny J.G., Haynes C.A., Kilburn D.G. Dynamic localization and persistent stimulation of factor-dependent cells by a stem cell factor/cellulose binding domain fusion protein. Biotechnol Bioeng 2005, 91(3):314-324.
35. Kirouac D.C., Madlambayan G.J., Yu M., Sykes E.A., Ito C., Zandstra P.W. Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol 2009, 5:293.
36. Kishimoto S., Nakamura S., Nakamura S., Hattori H., Oonuma F., Kanatani Y., et al. Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells. J Control Release 2009, 133(3):185-190.
37. LaIuppa J.A., Papoutsakis E.T., Miller W.M. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol 1998, 26(9):835-843.
38. Lapillonne H., Kobari L., Mazurier C., Tropel P., Giarratana M.C., Zanella-Cleon I., et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica 2010, 95(10):1651-1659.
39. Leberbauer C., Boulmé F., Unfried G., Huber J., Beug H., Müllner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005, 105(1):85-94.
40. Lu S.-J., Feng Q., Park J.S., Vida L., Lee B.-S., Strausbauch M., et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008, 112(12):4475-4484.
41. Madkaikar M., Ghosh K., Gupta M., Swaminathan S., Mohanty D. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol 2007, 118(3):153-159.
42. Madlambayan G.J., Rogers I., Purpura K.A., Ito C., Yu M., Kirouac D., et al. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant 2006, 12(10):1020-1030.
43. Martin Y., Vermette P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 2005, 26(35):7481-7503.
44. McAdams T.A., Miller W.M., Papoutsakis E.T. pH is a potent modulator of erythroid differentiation. Br J Haematol 1998, 103(2):317-325.
45. Miharada K., Hiroyama T., Sudo K., Nagasawa T., Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006, 24(10):1255-1256.
46. Nakamura Y., Hiroyama T., Miharada K., Kurita R. Red blood cell production from immortalized progenitor cell line. Int J Hematol 2011, 93(1):5-9.
47. Peerani R., Zandstra P.W. Enabling stem cell therapies through synthetic stem cell-niche engineering. J Clin Invest 2010, 120(1):60-70.
48. Perugini M., Varelias A., Sadlon T., D'Andrea R.J. Hematopoietic growth factor mimetics: from concept to clinic. Cytokine Growth Factor Rev 2009, 20(1):87-94.
49. Pharr P.N., Hankins D., Hofbauer A., Lodish H.F., Longmore G.D. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc Natl Acad Sci USA 1993, 90(3):938-942.
50. Pless G. Bioartificial liver support systems. Methods Mol Biol 2010, 640:511-523.
51. Pompe T., Salchert K., Alberti K., Zandstra P., Werner C. Immobilization of growth factors on solid supports for the modulation of stem cell fate. Nat Protoc 2010, 5(6):1042-1050.
52. Suzuki T., Yokoyama Y., Kumano K., Takanashi M., Kozuma S., Takato T., et al. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells 2006, 24(11):2456-2465.
53. Szabo E., Rampalli S., Risueño R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468(7323):521-526.
54. Timmins N.E., Nielsen L.K. Blood cell manufacture: current methods and future challenges. Trends Biotechnol 2009, 27(7):415-422.
55. Tung S.S., Parmar S., Robinson S.N., De Lima M., Shpall E.J. Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol 2010, 23(2):245-257.
56. Watts K.L., Delaney C., Humphries R.K., Bernstein I., Kiem H.-P. Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells. Blood 2010, 116(26):5859-5866.
57. Whitaker B.I., Henry R.A. The 2007 Nationwide Blood Collection and Utilization Survey Report 2007, Department of Health and Human Services, USA.
58. World Health Organization Global database on blood safety: report 2004-2005 2008, World Health Organization, Geneva.
59. Yang H., Miller W.M., Papoutsakis E.T. Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells 2002, 20(4):320-328.
60. Zhang C.C., Kaba M., Ge G., Xie K., Tong W., Hug C., et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 2006, 12(2):240-245.